These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 21344415)

  • 1. Single-step preparation and deagglomeration of itraconazole microflakes by supercritical antisolvent method for dissolution enhancement.
    Sathigari SK; Ober CA; Sanganwar GP; Gupta RB; Babu RJ
    J Pharm Sci; 2011 Jul; 100(7):2952-65. PubMed ID: 21344415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous production and co-mixing of microparticles of nevirapine with excipients by supercritical antisolvent method for dissolution enhancement.
    Sanganwar GP; Sathigari S; Babu RJ; Gupta RB
    Eur J Pharm Sci; 2010 Jan; 39(1-3):164-74. PubMed ID: 19961931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and pharmaceutical characterization of amorphous cefdinir using spray-drying and SAS-process.
    Park J; Park HJ; Cho W; Cha KH; Kang YS; Hwang SJ
    Int J Pharm; 2010 Aug; 396(1-2):239-45. PubMed ID: 20599602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced dissolution of megestrol acetate microcrystals prepared by antisolvent precipitation process using hydrophilic additives.
    Cho E; Cho W; Cha KH; Park J; Kim MS; Kim JS; Park HJ; Hwang SJ
    Int J Pharm; 2010 Aug; 396(1-2):91-8. PubMed ID: 20558265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying.
    Hu J; Ng WK; Dong Y; Shen S; Tan RB
    Int J Pharm; 2011 Feb; 404(1-2):198-204. PubMed ID: 21056643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying.
    Parikh T; Sandhu HK; Talele TT; Serajuddin AT
    Pharm Res; 2016 Jun; 33(6):1456-71. PubMed ID: 26951566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hot-melt extrusion for enhanced delivery of drug particles.
    Miller DA; McConville JT; Yang W; Williams RO; McGinity JW
    J Pharm Sci; 2007 Feb; 96(2):361-76. PubMed ID: 17075869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative physicochemical characterization of phospholipids complex of puerarin formulated by conventional and supercritical methods.
    Li Y; Yang DJ; Chen SL; Chen SB; Chan AS
    Pharm Res; 2008 Mar; 25(3):563-77. PubMed ID: 17828444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension.
    Zhang K; Yu H; Luo Q; Yang S; Lin X; Zhang Y; Tian B; Tang X
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1285-92. PubMed ID: 23562534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and characterization of camptothecin (CPT)-loaded folate-conjugated dextran nanoparticles for tumor-targeted drug delivery using supercritical antisolvent method.
    Zhao X; Wang D; Zu Y; Jiang R; Zhao D; Li Y; Zu B; Sun Z; Zhang Q
    J Control Release; 2011 Nov; 152 Suppl 1():e90-2. PubMed ID: 22195950
    [No Abstract]   [Full Text] [Related]  

  • 11. Formation of bicalutamide nanodispersion for dissolution rate enhancement.
    Li C; Li C; Le Y; Chen JF
    Int J Pharm; 2011 Feb; 404(1-2):257-63. PubMed ID: 21093558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties.
    Duret C; Wauthoz N; Sebti T; Vanderbist F; Amighi K
    Int J Pharm; 2012 May; 428(1-2):103-13. PubMed ID: 22414388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Itraconazole solid dispersion prepared by a supercritical fluid technique: preparation, in vitro characterization, and bioavailability in beagle dogs.
    Yin X; Daintree LS; Ding S; Ledger DM; Wang B; Zhao W; Qi J; Wu W; Han J
    Drug Des Devel Ther; 2015; 9():2801-10. PubMed ID: 26060397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process.
    Kim MS; Jin SJ; Kim JS; Park HJ; Song HS; Neubert RH; Hwang SJ
    Eur J Pharm Biopharm; 2008 Jun; 69(2):454-65. PubMed ID: 18359211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of wettability and dissolution properties of cilostazol using the supercritical antisolvent process: effect of various additives.
    Kim MS; Kim JS; Hwang SJ
    Chem Pharm Bull (Tokyo); 2010 Feb; 58(2):230-3. PubMed ID: 20118585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation, characterization and in vivo assessment of the bioavailability of glycyrrhizic acid microparticles by supercritical anti-solvent process.
    Sui X; Wei W; Yang L; Zu Y; Zhao C; Zhang L; Yang F; Zhang Z
    Int J Pharm; 2012 Feb; 423(2):471-9. PubMed ID: 22183131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a melt agglomeration process on agglomerates containing solid dispersions.
    Vilhelmsen T; Eliasen H; Schaefer T
    Int J Pharm; 2005 Oct; 303(1-2):132-42. PubMed ID: 16139973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and characterization study of itraconazole-loaded microparticles.
    Segale L; Giovannelli L; Mannina P; Pattarino F
    Pharm Dev Technol; 2015 Mar; 20(2):153-8. PubMed ID: 24219826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Original research paper. A superior preparation method for daidzein-hydroxypropyl-β-cyclodextrin complexes with improved solubility and dissolution: Supercritical fluid process.
    Pan H; Wang HB; Yu YB; Cheng BC; Wang XY; Li Y
    Acta Pharm; 2017 Mar; 67(1):85-97. PubMed ID: 28231046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of megestrol acetate solid dispersion nanoparticles for enhanced oral delivery by using a supercritical antisolvent process.
    Ha ES; Kim JS; Baek IH; Yoo JW; Jung Y; Moon HR; Kim MS
    Drug Des Devel Ther; 2015; 9():4269-77. PubMed ID: 26345723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.